NCT03548285View on ClinicalTrials.gov

Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

April 25, 2023

Study Completion Date

April 30, 2024

Conditions
Glottic Carcinoma
Interventions
RADIATION

Radiation therapy

Stereotactic ablative radiotherapy (SABR), also known as stereotactic body radiation therapy (SBRT)

Trial Locations (1)

75390

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT03548285 - Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer | Biotech Hunter | Biotech Hunter